Vilobelimab for Severe COVID-19 and Possibly Other Diseases
Roger Seheult, MD of MedCram examines vilobelimab in the treatment of severe COVID with possible applications in the treatment of other diseases. See all Dr. Seheult's videos at: https://www.medcram.com/?utm_source=Youtube&utm_medium=Video&utm_campaign=Video+Link+Clicks&utm_term=Vilobelimab+for+Severe+COVID-19+and+Possibly+Other+Diseases&utm_content=MVqeeVlmWZ4
(This video was recorded on May 7th, 2023)
Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com/?utm_source=Youtube&utm_medium=Video&utm_campaign=Video+Link+Clicks&utm_term=Vilobelimab+for+Severe+COVID-19+and+Possibly+Other+Diseases&utm_content=MVqeeVlmWZ4
He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.
LINKS / REFERENCES:
Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition (Clinical Immunology) | https://www.sciencedirect.com/science/article/abs/pii/S1521661617301729?via%3Dihub
The anti-C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID-19 (Clinical and translational science) | https://pubmed.ncbi.nlm.nih.gov/35029045/
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial (Lancet Respir Med) | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451499/pdf/main.pdf
Treatment With Anti-C5a Antibody Improves the Outcome of H7N9 Virus Infection in African Green Monkeys (Clinical infectious diseases) | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112341/
FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR GOHIBIC (FDA) | https://www.fda.gov/media/166824/download
COVID-19 Ventilator Course: Learn or Review Mechanical Ventilation (MedCram) | https://www.medcram.com/courses/COVID19-ventilator-mechanical-ventilation?utm_source=Youtube&utm_medium=Video&utm_campaign=Video+Link+Clicks&utm_term=Vilobelimab+for+Severe+COVID-19+and+Possibly+Other+Diseases&utm_content=MVqeeVlmWZ4
All coronavirus updates are at MedCram.com (including more discussion on delta variant covid, COVID Delta, COVID children, natural immunity COVID 19, and more).
MedCram Update 46: https://youtu.be/EFRwnhfWXxo
MedCram Update 47: https://youtu.be/H1LHgyfPPQ8
MedCram Update 132: https://youtu.be/9OZZ6_M4OB0
SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:
https://www.youtube.com/user/MEDCRAMvideos?sub_confirmation=1
Get notified of new videos by hitting the bell icon
MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:
MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.
MEDIA CONTACT:
Media Contact: customers@medcram.com
Media contact info: https://www.medcram.com/pages/media-contact?utm_source=Youtube&utm_medium=Video&utm_campaign=Video+Link+Clicks&utm_term=Vilobelimab+for+Severe+COVID-19+and+Possibly+Other+Diseases&utm_content=MVqeeVlmWZ4
Video Produced by Kyle Allred
FOLLOW US ON SOCIAL MEDIA:
https://www.facebook.com/MedCram
https://twitter.com/MedCramVideos
https://www.instagram.com/medcram
DISCLAIMER:
MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.
#COVID19 #Omicron #Coronavirus
Видео Vilobelimab for Severe COVID-19 and Possibly Other Diseases канала MedCram - Medical Lectures Explained CLEARLY
(This video was recorded on May 7th, 2023)
Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com/?utm_source=Youtube&utm_medium=Video&utm_campaign=Video+Link+Clicks&utm_term=Vilobelimab+for+Severe+COVID-19+and+Possibly+Other+Diseases&utm_content=MVqeeVlmWZ4
He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.
LINKS / REFERENCES:
Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition (Clinical Immunology) | https://www.sciencedirect.com/science/article/abs/pii/S1521661617301729?via%3Dihub
The anti-C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID-19 (Clinical and translational science) | https://pubmed.ncbi.nlm.nih.gov/35029045/
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial (Lancet Respir Med) | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451499/pdf/main.pdf
Treatment With Anti-C5a Antibody Improves the Outcome of H7N9 Virus Infection in African Green Monkeys (Clinical infectious diseases) | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112341/
FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR GOHIBIC (FDA) | https://www.fda.gov/media/166824/download
COVID-19 Ventilator Course: Learn or Review Mechanical Ventilation (MedCram) | https://www.medcram.com/courses/COVID19-ventilator-mechanical-ventilation?utm_source=Youtube&utm_medium=Video&utm_campaign=Video+Link+Clicks&utm_term=Vilobelimab+for+Severe+COVID-19+and+Possibly+Other+Diseases&utm_content=MVqeeVlmWZ4
All coronavirus updates are at MedCram.com (including more discussion on delta variant covid, COVID Delta, COVID children, natural immunity COVID 19, and more).
MedCram Update 46: https://youtu.be/EFRwnhfWXxo
MedCram Update 47: https://youtu.be/H1LHgyfPPQ8
MedCram Update 132: https://youtu.be/9OZZ6_M4OB0
SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:
https://www.youtube.com/user/MEDCRAMvideos?sub_confirmation=1
Get notified of new videos by hitting the bell icon
MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:
MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.
MEDIA CONTACT:
Media Contact: customers@medcram.com
Media contact info: https://www.medcram.com/pages/media-contact?utm_source=Youtube&utm_medium=Video&utm_campaign=Video+Link+Clicks&utm_term=Vilobelimab+for+Severe+COVID-19+and+Possibly+Other+Diseases&utm_content=MVqeeVlmWZ4
Video Produced by Kyle Allred
FOLLOW US ON SOCIAL MEDIA:
https://www.facebook.com/MedCram
https://twitter.com/MedCramVideos
https://www.instagram.com/medcram
DISCLAIMER:
MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.
#COVID19 #Omicron #Coronavirus
Видео Vilobelimab for Severe COVID-19 and Possibly Other Diseases канала MedCram - Medical Lectures Explained CLEARLY
Показать
Комментарии отсутствуют
Информация о видео
8 мая 2023 г. 18:00:13
00:17:57
Другие видео канала
Red Light Therapy Reduces Blood Glucose and Increases Metabolic RateMicroplastics in Our Food and Body: Cutting Boards, Microwaves, MoreCurrent COVID Risk Assessment: BA.2.86 Variant, Boosters, and MoreConquer Jet Lag with Light and MelatoninSugar from fruit does not have the same effect as added sugar in processed foods and drinks!The Low-Carb Fruit FallacyMinimal Exercise May Reduce DepressionPeter Attia, MD: How to Detect Cancer Early - Before it SpreadsLow Carb Diets: Mortality and Diabetes Long Term DataSimple tips on how to reduce allergies.Hydrocortisone Reduces Mortality by 48% in Severe Community-Acquired PneumoniaThe Vasopressor Trap - What It Is and How to Get Out of ItFor improved insulin sensitivity, consider making your bedroom as dark as possible at night.ECG/EKG Versus Smartwatch for Myocarditis/Pericarditis and Myocardial InfarctionPeeing at night is a symptom of obstructive sleep apnea Encephalitis After COVID-19 Vaccine Administration: PerspectivesWhat Ever Happened to Monkeypox?Largest H5N1 Outbreak in US History - Inching Closer to Human TransmissibilityWhat Happens When the Public Health Emergency Ends on May 11th, 2023Sleep deprivation during the week with catch up on the weekend is a cardiovascular risk factor